N. A. Buss, Monoclonal antibody therapeutics: history and future, Current Opinion in Pharmacology, vol.12, issue.5, pp.615-637, 2012.
DOI : 10.1016/j.coph.2012.08.001

D. L. Shawler, Human immune response to multiple injections of murine monoclonal IgG, J Immunol, vol.135, issue.2, pp.1530-1535, 1985.

P. T. Jones, Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature, vol.312, issue.6069, pp.321-522, 1986.
DOI : 10.1038/321522a0

C. Queen, A humanized antibody that binds to the interleukin 2 receptor., Proceedings of the National Academy of Sciences, vol.86, issue.24, pp.10029-10062, 1989.
DOI : 10.1073/pnas.86.24.10029

B. Al-lazikani, A. M. Lesk, and C. Chothia, Standard conformations for the canonical structures of immunoglobulins, Journal of Molecular Biology, vol.273, issue.4, pp.927-975, 1997.
DOI : 10.1006/jmbi.1997.1354

G. Winter and W. J. Harris, Humanized antibodies, Immunology Today, vol.14, issue.6, pp.243-249, 1993.
DOI : 10.1016/0167-5699(93)90039-N

Y. Safdari, Antibody humanization methods ??? a review and update, Biotechnology and Genetic Engineering Reviews, vol.5, issue.2, pp.175-86, 2013.
DOI : 10.1080/02648725.2013.801235

W. Y. Hwang and J. Foote, Immunogenicity of engineered antibodies, Methods, vol.36, issue.1, pp.3-10, 2005.
DOI : 10.1016/j.ymeth.2005.01.001

F. A. Harding, The immunogenicity of humanized and fully human antibodies, mAbs, vol.23, issue.3, pp.256-65, 2010.
DOI : 10.1093/annonc/mdm399

E. A. Padlan, Anatomy of the antibody molecule, Molecular Immunology, vol.31, issue.3, pp.31-169, 1994.
DOI : 10.1016/0161-5890(94)90001-9

N. R. Gonzales, SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity, Molecular Immunology, vol.41, issue.9, pp.41-863, 2004.
DOI : 10.1016/j.molimm.2004.03.041

S. O. Yoon, Construction, Affinity Maturation, and Biological Characterization of an Anti-tumor-associated Glycoprotein-72 Humanized Antibody, Journal of Biological Chemistry, vol.281, issue.11, pp.281-6985, 2006.
DOI : 10.1074/jbc.M511165200

K. S. Kim, Construction of a humanized antibody to hepatitis B surface antigen by specificity-determining residues (SDR)-grafting and de-immunization, Biochemical and Biophysical Research Communications, vol.396, issue.2, pp.231-238, 2010.
DOI : 10.1016/j.bbrc.2010.04.071

D. Ganem and A. M. Prince, Hepatitis B Virus Infection ??? Natural History and Clinical Consequences, New England Journal of Medicine, vol.350, issue.11, pp.350-1118, 2004.
DOI : 10.1056/NEJMra031087

K. H. Heermann, Large surface proteins of hepatitis B virus containing the pres sequence, J Virol, vol.52, issue.2, pp.396-402, 1984.

G. R. Dreesman, Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides, Nature, vol.78, issue.5845, pp.295-158, 1982.
DOI : 10.1038/295158a0

K. H. Heermann, Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees, Intervirology Proc Natl Acad Sci, vol.28, issue.1823, pp.14-25, 1986.

M. Q. Klinkert, Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective, J Virol Vaccine, vol.58, issue.73, pp.522-527, 1986.

A. R. Neurath, Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus, Cell, vol.46, issue.3, pp.429-465, 1986.
DOI : 10.1016/0092-8674(86)90663-X

P. Pontisso, Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles, Virology, vol.173, issue.2, pp.522-552, 1989.
DOI : 10.1016/0042-6822(89)90564-3

L. Seyec and J. , Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain, J Virol, vol.73, issue.3, pp.2052-2059, 1999.

P. Gripon, Infection of a human hepatoma cell line by hepatitis B virus, Proc Natl Acad Sci U S A, issue.24, pp.99-15655, 2002.

D. Glebe, Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus, J Virol, issue.17, pp.77-9511, 2003.

P. Gripon, I. Cannie, and S. Urban, Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein, Journal of Virology, vol.79, issue.3, pp.79-1613, 2005.
DOI : 10.1128/JVI.79.3.1613-1622.2005

J. Salisse and C. Sureau, A Function Essential to Viral Entry Underlies the Hepatitis B Virus "a" Determinant, Journal of Virology, vol.83, issue.18, pp.83-9321, 2009.
DOI : 10.1128/JVI.00678-09

H. Yan, Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus, Elife, issue.1, p.49, 2012.

C. Sureau and J. Salisse, A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant, Hepatology, vol.35, issue.Suppl. 1, pp.985-94, 2013.
DOI : 10.1002/hep.26125

R. P. Beasley, Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine, Lancet, issue.28359, pp.1099-102, 1983.

R. W. Mcgory, IMPROVED OUTCOME OF ORTHOTOPIC LIVER TRANSPLANTATION FOR CHRONIC HEPATITIS B CIRRHOSIS WITH AGGRESSIVE PASSIVE IMMUNIZATION, Transplantation, vol.61, issue.9, pp.61-1358, 1996.
DOI : 10.1097/00007890-199605150-00013

N. A. Terrault, Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin, Hepatology, vol.24, issue.6, pp.1327-1360, 1996.
DOI : 10.1002/hep.510240601

C. J. Ryu, Short Communication: Mouse Monoclonal Antibodies to Hepatitis B Virus PreS1 Produced After Immunization with Recombinant PreS1 Peptide, Hybridoma, vol.19, issue.2, pp.185-194, 2000.
DOI : 10.1089/02724570050031248

C. Y. Maeng, Fine Mapping of Virus-Neutralizing Epitopes on Hepatitis B Virus PreS1, Virology, vol.270, issue.1, pp.9-16, 2000.
DOI : 10.1006/viro.2000.0250

H. J. Hong, In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees, Virology, vol.318, issue.1, pp.318-134, 2004.
DOI : 10.1016/j.virol.2003.09.014

S. W. Chi, Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism, Proceedings of the National Academy of Sciences, vol.104, issue.22, pp.9230-9235, 2007.
DOI : 10.1073/pnas.0701279104

J. K. Min, L1 Cell Adhesion Molecule Is a Novel Therapeutic Target in Intrahepatic Cholangiocarcinoma, Clinical Cancer Research, vol.16, issue.14, pp.16-3571, 2010.
DOI : 10.1158/1078-0432.CCR-09-3075

M. S. Oh, A new epitope tag from hepatitis B virus preS1 for immunodetection, localization and affinity purification of recombinant proteins, Journal of Immunological Methods, vol.283, issue.1-2, pp.77-89, 2003.
DOI : 10.1016/j.jim.2003.08.010

M. A. Sells, M. L. Chen, and G. Acs, Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA., Proceedings of the National Academy of Sciences, vol.84, issue.4, pp.1005-1014, 1987.
DOI : 10.1073/pnas.84.4.1005

P. Gripon, Myristylation of the Hepatitis B Virus Large Surface Protein Is Essential for Viral Infectivity, Virology, vol.213, issue.2, pp.292-301, 1995.
DOI : 10.1006/viro.1995.0002

F. Galibert, Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli, Nature, vol.5, issue.5733, pp.281-646, 1979.
DOI : 10.1016/0092-8674(78)90070-3

J. Hayer, HBVdb: a knowledge database for Hepatitis B Virus, Nucleic Acids Research, vol.41, issue.D1, pp.41-566, 2013.
DOI : 10.1093/nar/gks1022
URL : https://hal.archives-ouvertes.fr/hal-00965883

C. J. Ryu, In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen, Journal of Medical Virology, vol.13, issue.2, pp.226-259, 1997.
DOI : 10.1002/(SICI)1096-9071(199706)52:2<226::AID-JMV18>3.0.CO;2-I

H. S. Kim and H. J. Hong, Efficient expression, purification and characterization of hepatitis B virus preS1 protein from Escherichia coli, Biotechnology Letters, vol.76, issue.8, pp.17-871, 1995.
DOI : 10.1007/BF00129021

P. Gripon, C. Diot, and C. Guguen-guillouzo, Reproducible High Level Infection of Cultured Adult Human Hepatocytes by Hepatitis B Virus: Effect of Polyethylene Glycol on Adsorption and Penetration, Virology, vol.192, issue.2, pp.534-574, 1993.
DOI : 10.1006/viro.1993.1069

C. M. Bremer, N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus, Journal of Hepatology, vol.55, issue.1, pp.29-37, 2011.
DOI : 10.1016/j.jhep.2010.10.019

H. Wu, Ultra-potent Antibodies Against Respiratory Syncytial Virus: Effects of Binding Kinetics and Binding Valence on Viral Neutralization, Journal of Molecular Biology, vol.350, issue.1, pp.126-170, 2005.
DOI : 10.1016/j.jmb.2005.04.049

H. Wu, Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract, Journal of Molecular Biology, vol.368, issue.3, pp.652-65, 2007.
DOI : 10.1016/j.jmb.2007.02.024

J. T. Bates, Reversion of somatic mutations of the respiratory syncytial virusspecific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency, J Immunol, issue.7, pp.190-3732, 2013.

T. C. Vancott, Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1, J Immunol, vol.153, issue.1, pp.449-59, 1994.

N. L. Kallewaard, Functional Maturation of the Human Antibody Response to Rotavirus, The Journal of Immunology, vol.180, issue.6, pp.3980-3989, 2008.
DOI : 10.4049/jimmunol.180.6.3980

F. G. Shirazi, Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection, J Gastroenterol Hepatol, issue.5, pp.29-1083, 2014.